RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+12.85%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.44B
AUM Growth
+$2.44B
(-5.2%)
Cap. Flow
-$46.4M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
50.14%
Holding
73
New
3
Increased
9
Reduced
33
Closed
4
Top Buys
| 1 |
Akero Therapeutics
AKRO
|
$57.1M |
| 2 |
Prime Medicine
PRME
|
$41M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$37.8M |
| 4 |
Replimune Group
REPL
|
$32.3M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$23.6M |
Top Sells
| 1 |
argenx
ARGX
|
$49.8M |
| 2 |
Prothena Corp
PRTA
|
$31.9M |
| 3 |
ONEM
1Life Healthcare, Inc. Common Stock
ONEM
|
$29.4M |
| 4 |
The Beauty Health Co
SKIN
|
$24.9M |
| 5 |
LivaNova
LIVN
|
$23.9M |
Sector Composition
| 1 | Healthcare | 98.91% |
| 2 | Industrials | 0.92% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $247M | 10.11% | 20,249,789 -1,469,402 | -7% | -$17.9M |
|
2
Krystal Biotech
KRYS
$4.27B
| $150M | 6.15% | 1,896,645 -2,900 | -0.2% | -$230K |
|
|
3
Akero Therapeutics
AKRO
$3.74B
| $144M | 5.9% | 2,632,912 +1,041,827 | +65% | +$57.1M |
|
|
4
Replimune Group
REPL
$422M
| $131M | 5.38% | 4,831,709 +1,186,400 | +33% | +$32.3M |
|
5
Fate Therapeutics
FATE
$120M
| $131M | 5.35% | 12,957,222 | – | – |
|
|
ISEE
6
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $96.4M | 3.94% | 4,502,111 +1,102,211 | +32% | +$23.6M |
|
7
Xenon Pharmaceuticals
XENE
$2.98B
| $93.1M | 3.81% | 2,360,414 -10,200 | -0.4% | -$402K |
|
8
Celldex Therapeutics
CLDX
$1.47B
| $88.1M | 3.61% | 1,977,451 -7,700 | -0.4% | -$343K |
|
9
Pliant Therapeutics
PLRX
$101M
| $75M | 3.07% | 3,878,599 -629,605 | -14% | -$12.2M |
|
10
Beam Therapeutics
BEAM
$1.66B
| $69.2M | 2.83% | 1,770,587 -2,400 | -0.1% | -$93.9K |
|
11
Kymera Therapeutics
KYMR
$2.95B
| $66.7M | 2.73% | 2,673,837 -202,800 | -7% | -$5.06M |
|
|
12
LivaNova
LIVN
$3.08B
| $61.4M | 2.51% | 1,106,409 -429,953 | -28% | -$23.9M |
|
|
DCPH
13
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $58.9M | 2.41% | 3,593,317 +620,288 | +21% | +$10.2M |
|
|
IGMS
14
DELISTED
IGM Biosciences
IGMS
| $56.7M | 2.32% | 3,334,355 | – | – |
|
|
15
argenx
ARGX
$43.6B
| $56.3M | 2.3% | 148,517 -131,509 | -47% | -$49.8M |
|
|
16
Jazz Pharmaceuticals
JAZZ
$7.75B
| $50.8M | 2.08% | 318,945 +237,481 | +292% | +$37.8M |
|
17
Penumbra
PEN
$10.6B
| $49.3M | 2.02% | 221,809 +43,017 | +24% | +$9.57M |
|
18
Zymeworks
ZYME
$1.12B
| $48.5M | 1.99% | 6,175,918 +410,100 | +7% | +$3.22M |
|
19
Regenxbio
RGNX
$451M
| $43.4M | 1.78% | 1,913,512 -3,700 | -0.2% | -$83.9K |
|
|
IMGN
20
DELISTED
Immunogen Inc
IMGN
| $42.3M | 1.73% | 8,532,817 -15,328 | -0.2% | -$76K |
|
|
21
Prime Medicine
PRME
$578M
| $41M | 1.68% | +2,209,350 | New | +$41M |
|
22
Repare Therapeutics
RPTX
$71.7M
| $39.5M | 1.62% | 2,684,396 | – | – |
|
|
ONEM
23
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $38.9M | 1.59% | 2,326,625 -1,761,000 | -43% | -$29.4M |
|
24
Nurix Therapeutics
NRIX
$714M
| $32.9M | 1.35% | 3,000,784 -5,900 | -0.2% | -$64.8K |
|
|
OSH
25
DELISTED
Oak Street Health, Inc.
OSH
| $30.6M | 1.25% | 1,420,617 +359,322 | +34% | +$7.73M |
|